Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment

Metabolism. 2011 Jun;60(6):749-53. doi: 10.1016/j.metabol.2010.09.011. Epub 2010 Oct 20.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adiponectin / metabolism
  • Adipose Tissue / physiopathology*
  • Antiretroviral Therapy, Highly Active / adverse effects*
  • Dyslipidemias / blood
  • Dyslipidemias / chemically induced
  • Dyslipidemias / physiopathology
  • Fatty Acids, Nonesterified / metabolism
  • Glycerol / metabolism
  • HIV Infections / drug therapy*
  • HIV Infections / physiopathology*
  • HIV-Associated Lipodystrophy Syndrome / blood*
  • HIV-Associated Lipodystrophy Syndrome / drug therapy
  • HIV-Associated Lipodystrophy Syndrome / physiopathology
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Lipolysis / physiology
  • PPAR gamma / agonists
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use

Substances

  • Adiponectin
  • Fatty Acids, Nonesterified
  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Rosiglitazone
  • Glycerol